111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
51.63%
Revenue growth exceeding 1.5x CX's 13.06%. David Dodd would verify if faster growth reflects superior business model.
No Data
No Data available this quarter, please select a different quarter.
51.63%
Gross profit growth exceeding 1.5x CX's 23.58%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.63%
EBITDA growth 50-75% of CX's 75.20%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
51.63%
Operating income growth 50-75% of CX's 70.77%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Similar other expenses growth to CX's 110.55%. Walter Schloss would investigate industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-114.00%
Tax expense reduction while CX shows 95.05% growth. Joel Greenblatt would examine advantage.
114.00%
Net income growth while CX declines. John Neff would investigate advantages.
41.13%
Net margin growth while CX declines. John Neff would investigate advantages.
100.00%
EPS growth while CX declines. John Neff would investigate advantages.
100.00%
Diluted EPS growth while CX declines. John Neff would investigate advantages.
7.00%
Share count change of 7.00% while CX is stable. Bruce Berkowitz would verify approach.
7.00%
Diluted share change of 7.00% while CX is stable. Bruce Berkowitz would verify approach.